Moxifloxacin: new fluoroquinolone for bacterial conjunctivitis

    loading  Checking for direct PDF access through Ovid

Abstract

KEY POINTS

Moxifloxacin (Moxivig) is a fourth-generation fluoroquinolone for use in bacterial conjunctivitis. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse events, and Dr Adrian Tey discusses its potential role in the treatment of conjunctivitis.

Related Topics

    loading  Loading Related Articles